Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pigazzini Ml"'
Publikováno v:
Neuro-Oncology. 19:i15-i15
Primary brain tumours are greatly diverse and are classified according to histological features, anatomical location, childhood versus adult onset, plus in a few cases genetic and epigenetic modifications. The outcome of (epi)genetic perturbations ca
Autor:
Montresor S; Department of Cell Biology, University of Bremen, Bremen, Germany., Pigazzini ML; Leibniz Institute for Molecular Pharmacology, Berlin, Germany., Baskaran S; Leibniz Institute on Aging-Fritz-Lipmann-Institute, Jena, Germany., Sleiman M; Department of Cell Biology, University of Bremen, Bremen, Germany.; Leibniz Institute on Aging-Fritz-Lipmann-Institute, Jena, Germany., Adhikari G; Leibniz Institute on Aging-Fritz-Lipmann-Institute, Jena, Germany., Basilicata L; Department of Cell Biology, University of Bremen, Bremen, Germany., Secker L; Department of Cell Biology, University of Bremen, Bremen, Germany., Jacob N; Department of Cell Biology, University of Bremen, Bremen, Germany., Ehlert Y; Department of Cell Biology, University of Bremen, Bremen, Germany., Kelkar A; Department of Cell Biology, University of Bremen, Bremen, Germany., Kalsi GK; Department of Cell Biology, University of Bremen, Bremen, Germany., Kulkarni N; Department of Cell Biology, University of Bremen, Bremen, Germany., Spellerberg P; Department of Cell Biology, University of Bremen, Bremen, Germany., Kirstein J; Leibniz Institute on Aging-Fritz-Lipmann-Institute, Jena, Germany.; Friedrich-Schiller-Universität, Institute for Biochemistry & Biophysics, Jena, Germany.
Publikováno v:
Journal of neurochemistry [J Neurochem] 2024 Aug 23. Date of Electronic Publication: 2024 Aug 23.
Autor:
Ayala Mariscal SM; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany., Pigazzini ML; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany.; NeuroCure Cluster of Excellence, Charité Universitätsmedizin Berlin, Berlin, Germany., Richter Y; Department of Cell Biology, University of Bremen, Bremen, Germany., Özel M; Department of Cell Biology, University of Bremen, Bremen, Germany., Grothaus IL; Hybrid Materials Interfaces Group, Faculty of Production Engineering and Bremen Center for Computational Materials Science, University of Bremen, Bremen, Germany.; Center for Environmental Research and Sustainable Technology (UFT), University of Bremen, Bremen, Germany., Protze J; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany., Ziege K; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany., Kulke M; MSU-DOE-Plant Research Laboratory, Michigan State University, 612 Wilson Road, East Lansing, MI, 48824, USA., ElBediwi M; Department of Cell Biology, University of Bremen, Bremen, Germany., Vermaas JV; MSU-DOE-Plant Research Laboratory, Michigan State University, 612 Wilson Road, East Lansing, MI, 48824, USA., Colombi Ciacchi L; Hybrid Materials Interfaces Group, Faculty of Production Engineering and Bremen Center for Computational Materials Science, University of Bremen, Bremen, Germany.; Center for Environmental Research and Sustainable Technology (UFT), University of Bremen, Bremen, Germany.; MAPEX Bremen Center for Materials and Processes, University of Bremen, Bremen, Germany., Köppen S; Hybrid Materials Interfaces Group, Faculty of Production Engineering and Bremen Center for Computational Materials Science, University of Bremen, Bremen, Germany.; MAPEX Bremen Center for Materials and Processes, University of Bremen, Bremen, Germany., Liu F; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany., Kirstein J; Leibniz Research Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany. kirstein@uni-bremen.de.; Department of Cell Biology, University of Bremen, Bremen, Germany. kirstein@uni-bremen.de.
Publikováno v:
Nature communications [Nat Commun] 2022 Aug 10; Vol. 13 (1), pp. 4692. Date of Electronic Publication: 2022 Aug 10.
Autor:
Pigazzini ML; Department of Molecular Physiology and Cell Biology, Leibniz Research Institute for Molecular Pharmacology in the Forschungsverbund Berlin e.V. (FMP), Berlin, Germany.; NeuroCure Cluster of Excellence, Charité Universitätsmedizin Berlin, Berlin, Germany., Lawrenz M; Department of Molecular Physiology and Cell Biology, Leibniz Research Institute for Molecular Pharmacology in the Forschungsverbund Berlin e.V. (FMP), Berlin, Germany., Margineanu A; Advanced Light Microscopy, Max-Delbrück Centrum for Molecular Medicine (MDC), Berlin, Germany., Kaminski Schierle GS; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom., Kirstein J; Department of Molecular Physiology and Cell Biology, Leibniz Research Institute for Molecular Pharmacology in the Forschungsverbund Berlin e.V. (FMP), Berlin, Germany.; Department of Cell Biology, University of Bremen, Bremen, Germany.
Publikováno v:
Frontiers in molecular neuroscience [Front Mol Neurosci] 2021 Oct 15; Vol. 14, pp. 721749. Date of Electronic Publication: 2021 Oct 15 (Print Publication: 2021).
Autor:
Pigazzini ML; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund; NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin., Kirstein J; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund; Department of Biology and Chemistry, University of Bremen; kirstein@uni-bremen.de.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2020 Jun 13 (160). Date of Electronic Publication: 2020 Jun 13.
Autor:
Pigazzini ML; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund Berlin; NeuroCure Cluster of Excellence, Charité - Universitätsmedizin Berlin., Gallrein C; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund Berlin., Iburg M; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund Berlin., Kaminski Schierle G; Molecular Neuroscience Group, Department of Chemical Engineering and Biotechnology, University of Cambridge., Kirstein J; Leibniz Research Institute for Molecular Pharmacology im Forschungsverbund Berlin; Cell Biology, University of Bremen; kirstein@uni-bremen.de.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2020 Mar 27 (157). Date of Electronic Publication: 2020 Mar 27.
Autor:
Nethisinghe S; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom., Pigazzini ML; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom., Pemble S; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery (NHNN), London, United Kingdom., Sweeney MG; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery (NHNN), London, United Kingdom., Labrum R; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery (NHNN), London, United Kingdom., Manso K; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom., Moore D; Molecular Genetics Laboratory, South East Scotland Genetics Service, Western General Hospital, Edinburgh, United Kingdom., Warner J; Molecular Genetics Laboratory, South East Scotland Genetics Service, Western General Hospital, Edinburgh, United Kingdom., Davis MB; Neurogenetics Unit, National Hospital for Neurology and Neurosurgery (NHNN), London, United Kingdom., Giunti P; Ataxia Centre, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
Publikováno v:
Frontiers in cellular neuroscience [Front Cell Neurosci] 2018 Jul 31; Vol. 12, pp. 200. Date of Electronic Publication: 2018 Jul 31 (Print Publication: 2018).
Autor:
Scior A; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany., Buntru A; Max Delbrueck Center for Molecular Medicine, Berlin, Germany., Arnsburg K; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany., Ast A; Max Delbrueck Center for Molecular Medicine, Berlin, Germany., Iburg M; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany., Juenemann K; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany., Pigazzini ML; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany.; Charité - Universitätsmedizin and NeuroCure Cluster of Excellence, Berlin, Germany., Mlody B; Max Delbrueck Center for Molecular Medicine, Berlin, Germany., Puchkov D; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany., Priller J; Department of Neuropsychiatry and Laboratory of Molecular Psychiatry, Charite Universitätsmedizin Berlin, Berlin, Germany., Wanker EE; Max Delbrueck Center for Molecular Medicine, Berlin, Germany ewanker@mdc-berlin.de kirstein@fmp-berlin.de., Prigione A; Max Delbrueck Center for Molecular Medicine, Berlin, Germany., Kirstein J; Leibniz-Institute for Molecular Pharmacology (FMP) im Forschungsverbund Berlin, Berlin, Germany ewanker@mdc-berlin.de kirstein@fmp-berlin.de.
Publikováno v:
The EMBO journal [EMBO J] 2018 Jan 17; Vol. 37 (2), pp. 282-299. Date of Electronic Publication: 2017 Dec 06.